|Bid||0.1800 x 0|
|Ask||0.2300 x 0|
|Day's Range||0.2000 - 0.2000|
|52 Week Range||0.1400 - 0.2700|
|Beta (5Y Monthly)||-0.17|
|PE Ratio (TTM)||11.76|
|Earnings Date||Jul. 24, 2017 - Jul. 25, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.25|
TORONTO, ON / ACCESSWIRE / November 19, 2020 / NEXGENRX INC.
This article will reflect on the compensation paid to Ron Loucks who has served as CEO of NexgenRx Inc. (CVE:NXG...
In 2003 Ron Loucks was appointed CEO of NexgenRx Inc. (CVE:NXG). This analysis aims first to contrast CEO compensation...